PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2120394
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2120394
According to Mordor Intelligence, the United States biopesticides market size was valued at USD 1.86 billion in 2025 and is estimated to grow from USD 2.10 billion in 2026 to USD 3.82 billion by 2031, at a CAGR of 12.7% during the forecast period (2026-2031).

This report is Segmented by Form (Biofungicides, Bioherbicides, and More) and by Crop Type (Cash Crops, Horticultural Crops, and Row Crops). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).
The expansion of organic farming and increasing demand for residue-compliant agricultural products are driving the adoption of biopesticides in the United States. Organic production standards prohibit most synthetic pesticides, while export-oriented fruit, vegetable, tree nut, and specialty crop growers are increasingly incorporating biological crop protection products to comply with maximum residue limit (MRL) requirements and retailer sustainability programs. Biopesticides are also being integrated into conventional farming systems as part of integrated pest management (IPM) strategies to reduce chemical residues while maintaining crop productivity. According to the United States Department of Agriculture (USDA) Economic Research Service (ERS), United States organic food sales reached a record USD 65.4 billion in 2024, reflecting continued growth in consumer demand for organically produced food and supporting the expansion of organic production systems. This trend is encouraging wider adoption of biopesticides across high-value crops, strengthening long-term growth in the United States biopesticides market.
The United States biopesticides market is supported by broader adoption of biological products across mainstream cropping systems. A 2025 Frontiers study in Insect Science reported that 45% of row-crop producers used biologicals in 2024, an increase of 8 percentage points from past 2 years. The same study found that 63% of leading agricultural retailers reported biological product sales growth during 2024. Seed treatments for Bt-resistant corn rootworm areas and foliar programs for soybean rust indicate that biological products are gaining roles beyond organic production. Southeast cotton programs are incorporating biofungicides for seedling disease management and bioinsecticides for bollworm populations with pyrethroid resistance. Bacillus-based products registered for multiple crops under a single label can reduce registration costs per acre and expand product access across corn, soybean, and specialty-crop systems.
The higher per-acre cost of biopesticides compared with conventional chemical pesticides remains a key barrier to adoption, particularly in broad-acre row crops where profit margins are relatively low. Microbial biopesticides often require specialized fermentation, formulation, and quality-control processes that increase production costs, while certain biological products also require more frequent applications to maintain efficacy under field conditions. As a result, growers in crops such as corn, soybean, and wheat may be reluctant to replace lower-cost synthetic pesticides unless clear economic benefits are demonstrated. Although improvements in domestic fermentation capacity, strain development, and manufacturing efficiency are anticipated to reduce production costs over time, price competitiveness remains a challenge. Consequently, suppliers in the United States biopesticides market must demonstrate measurable value through yield protection, resistance management, residue compliance, or premium market access to justify the higher treatment cost.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Biofungicides accounted for 49.0% of the United States biopesticides market share in 2025, making them the largest product segment. Their widespread adoption is driven by applications in seed treatment, soil drench, and foliar disease management across row crops, fruits, vegetables, and specialty crops. Biofungicides are widely used in certified organic production and increasingly integrated into conventional farming systems to manage diseases while supporting residue compliance and resistance-management strategies. Their established role in controlling soybean sudden death syndrome, corn seedling diseases, and cotton Rhizoctonia has reinforced their commercial position. By contrast, bioherbicides and other product categories remain smaller because achieving consistent weed control under diverse climatic and agronomic conditions continues to be a technical challenge.
Bioinsecticides are projected to expand at a 15.0% CAGR between 2026 and 2031, making them the fastest-growing product segment in the United States biopesticides market. Growth is driven by increasing demand for alternative modes of action to address insecticide resistance and support integrated pest management (IPM) programs. Product innovation and regulatory approvals continue to strengthen the segment's commercial potential. In February 2026, Vestaron received United States Environmental Protection Agency (EPA) approval for BASIN for outdoor agricultural use against lepidopteran pests and soft-bodied insects. This development expands biological insect-control options and supports the continued growth of the United States biopesticides market.